Latest Headlines
-
MECART Releases Highlights Of Peer-Reviewed Study Assessing Cleanroom Life-Cycle Environmental Impacts
4/22/2026
MECART, Corp. today announced results of a peer-reviewed life cycle assessment (LCA) that shows its cleanroom systems have lower environmental impacts than those of the average North American cleanroom.
- CDMO Nucleus RadioPharma Secures $50 Million Financing From OrbiMed to Expand Manufacturing Capacity 4/21/2026
-
Antares Vision Group To Present Denester-Inspection-Labeling Line For Prefilled Syringes At INTERPHEX 2026 Conference
4/17/2026
Antares Vision Group will offer live demonstrations of an integrated line providing automatic denesting, inspection and labeling for prefilled syringe production at Interphex Booth 2821.
-
Achieve Life Sciences Announces Operational Progress Including Completion Of Technology Transfer To Adare Pharma Solutions
4/15/2026
Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio.
-
Flow Sciences Appoints Kent Lupino As Chief Marketing Officer
4/14/2026
Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Kent Lupino as chief marketing officer. Lupino will be based at the company's new office in North Carolina's Research Triangle Park (RTP) and will report directly to Chief Executive Officer Jonathan Mann.
-
Groninger To Debut "Lifecycle Solutions" At INTERPHEX 2026
4/14/2026
At the show, groninger USA will debut its newly launched service concept, “Lifecycle Solutions.” The program consolidates all services across the entire lifecycle of the company’s machines – from commissioning and continuous optimization to modernization and retrofit. In doing so, it reflects the company’s ongoing commitment to service, quality, and providing long-term solutions availability.
- AST And Marchesini Group Debut Partnership Benefit With Expanded Drug Product Manufacturing Portfolio At INTERPHEX 2026 4/14/2026
-
Grand River Aseptic Manufacturing Announces $100 Million Investment In Sterile Manufacturing Capabilities
4/14/2026
Grand River Aseptic Manufacturing (“GRAM”), an Arlington Capital Partners portfolio company, is a leading provider of sterile fill-finish services. The company has announced a significant investment to expand its sterile injectable drug product manufacturing capacity and capabilities for high-volume commercial products.
- Ensorcell Launches Versaweld™ Precision Tube Welding Platform At INTERPHEX 2026 4/10/2026
- CleanSpace™ Debuts Massive Modular Cleanroom At Upcoming INTERPHEX 2026 Conference 4/9/2026